Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17617141 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL13575648 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL235849 | 0.87 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL13269547 | 0.84 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL3700073 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL638162 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL12868877 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL8980113 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL17617122 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM | |
| SCHEMBL17617126 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10ALOX15MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2693896-B1 | FRUITY FLAVORED COCOA PRODUCTS AND PROCESSES FOR PRODUCING SUCH COCOA PRODUCTS | OLAM INTERNATIONAL LTD (SG) | 2018-09-12 | — | — | EP | claimed |
| US-9362595-B2 | Nonaqueous electrolytic solution and energy storage device using same | UBE INDUSTRIES, LTD. (JP) | 2016-06-07 | — | — | US | claimed |
| US-20140030609-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-30 | — | — | US | claimed |
| CN-1177645-C | DMC complex catalyst and process for preparing the same | ���ʿ����о�����˾ | 2004-12-01 | — | — | CN | claimed |
| US-6699961-B2 | DOUBLE METAL CYANIDE (DMC); SPECIFIC LIQUID IS ADDED AFTER FORMATION OF THE DMC CATALYST PARTICLES, WHICH EFFECTS A PHASE SEPARATION RESULTING IN AN AQUEOUS PHASE CONTAINING THE SALTS AND A CATALYST CONTAINING PHASE FLOATING THEREON | SHELL OIL COMPANY | 2004-03-02 | — | — | US | claimed |
| EP-1276562-B1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INT RESEARCH (NL) | 2003-09-17 | — | — | EP | claimed |
| CN-1426325-A | DMC complex catalyst and process for its preparation | SHELL INT RESEARCH (NL) | 2003-06-25 | — | — | CN | claimed |
| US-20030069389-A1 | Dmc complex catalyst and process for its preparation | SHELL OIL COMPANY | 2003-04-10 | — | — | US | claimed |
| EP-1276562-A1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2003-01-22 | — | — | EP | claimed |
| WO-2001072418-A1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2001-10-04 | — | — | WO | claimed |
| CN-106602013-B | Preparation method of sulfur-activated carbon/graphene composite material | 中国科学院山西煤炭化学研究所 | 2020-11-27 | — | — | CN | disclosed |
| US-9586931-B2 | Triazolyl derivatives as Syk inhibitors | MERCK SHARP & DOHME CORP. (US) | 2017-03-07 | — | — | US | disclosed |
| US-9362595-B2 | Nonaqueous electrolytic solution and energy storage device using same | UBE INDUSTRIES, LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
| US-9173395-B2 | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-11-03 | — | — | US | disclosed |
| US-20030069389-A1 | Dmc complex catalyst and process for its preparation | SHELL OIL COMPANY | 2003-04-10 | — | — | US | disclosed |
| WO-2003008482-A1 | DOUBLE METAL COMPLEX CATALYST | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2003-01-30 | — | — | WO | disclosed |
| US-20030023022-A1 | Double metal complex catalyst | SHELL OIL COMPANY | 2003-01-30 | — | — | US | disclosed |
| EP-1276562-A1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2003-01-22 | — | — | EP | disclosed |
| WO-2001072418-A1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2001-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | ALDH1A1 236/4885LMNA 4014/4885HSD17B10 437/4885 |
| US-20030069389-A1 | Dmc complex catalyst and process for its preparation | INO80C, DKC1, MLEC | ALDH1A1 4525/4885LMNA 80/4885HSD17B10 877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.